Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.

Zebisch M, Kölbl AC, Schindlbeck C, Neugebauer J, Heublein S, Ilmer M, Rack B, Friese K, Jeschke U, Andergassen U.

Anticancer Res. 2012 Dec;32(12):5387-91.

PMID:
23225441
3.

Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.

Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.

Anticancer Res. 2003 Mar-Apr;23(2C):1883-90.

PMID:
12820473
4.

Detection of circulating tumor cells in metastatic breast cancer patients.

Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S.

Endocr Regul. 2011 Jul;45(3):113-24.

PMID:
21793623
5.

[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].

Cai QQ, Huang HQ, Lin TX, Jiang WQ.

Ai Zheng. 2005 Jul;24(7):837-41. Chinese.

PMID:
16004811
6.

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES.

Clin Cancer Res. 2003 Nov 1;9(14):5145-51.

7.

Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.

Grünewald K, Haun M, Urbanek M, Fiegl M, Müller-Holzner E, Gunsilius E, Dünser M, Marth C, Gastl G.

Lab Invest. 2000 Jul;80(7):1071-7.

PMID:
10908152
8.

Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.

Fabisiewicz A, Kulik J, Kober P, Brewczyńska E, Pieńkowski T, Siedlecki JA.

Acta Biochim Pol. 2004;51(3):747-55.

9.
10.

Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System.

Ji XQ, Sato H, Tanaka H, Konishi Y, Fujimoto T, Takahashi O, Tanaka T.

Gynecol Oncol. 2006 Feb;100(2):355-60.

PMID:
16203027
11.

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

Tunca B, Egeli U, Cecener G, Tezcan G, Gökgöz S, Tasdelen I, Bayram N, Tolunay S, Umut G, Demirdogen E, Erturk E, Ak S, Cetintas S, Evrensel T.

Tumori. 2012 Mar-Apr;98(2):243-51. doi: 10.1700/1088.11937.

PMID:
22677992
12.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

Br J Cancer. 2009 Aug 18;101(4):589-97. doi: 10.1038/sj.bjc.6605183.

13.

The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.

Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y, Coombes RC.

Eur J Cancer. 1997 May;33(6):854-61.

PMID:
9291805
14.

Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay.

Zehentner BK, Secrist H, Hayes DC, Zhang X, Ostenson RC, Loop S, Goodman G, Houghton RL, Persing DH.

Mol Diagn Ther. 2006;10(1):41-7.

PMID:
16646576
15.

Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer.

Serrano MJ, Sánchez-Rovira P, Delgado-Rodriguez M, Gaforio JJ.

Cancer Biol Ther. 2009 Apr;8(8):671-5.

PMID:
19242121
16.

Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.

Felton T, Harris GC, Pinder SE, Snead DR, Carter GI, Bell JA, Haines A, Kollias J, Robertson JF, Elston CW, Ellis IO.

Breast. 2004 Feb;13(1):35-41.

PMID:
14759714
17.

[Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].

López Guerrero JA, Bolufer P, Barragán E, Sanz Alonso M, Palau J, Sempere A, De la Rubia J, Bonanad S, Torregrosa MD.

Sangre (Barc). 1996 Dec;41(6):441-6. Spanish.

PMID:
9148421
19.

Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.

de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A, Pouillart P, Magdelénat H.

Clin Cancer Res. 2000 Aug;6(8):3117-22.

20.
Items per page

Supplemental Content

Support Center